A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults
Mayo Clinic · with National Institute on Aging (NIA) · NCT06820658
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- February 26, 2025
- Record last updated
- August 5, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of the study is to use neurological techniques to obtain quantitative measurements of nervous system control of skeletal muscle activity in adults aged 60-85 who are either long-term resistance exercisers or who are untrained.
Being studied: Neuromuscular Test; DEXA; Mixed Meal Tolerance Test; Strength Test
Conditions: Healthy; Insulin Resistance
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Participant must have a BMI between 18.5 and 38
- Participant be aged between 60 and 85
- Regularly exercises at least 5 days a week a minimum of 30 minutes per day.
- Engages in less than 2 days of exercise less than 30 minutes each day.
- Participant must use the Mayo Clinic patient online portal.
- Participant must be able to understand English without the need of an interpreter.
- Must be willing to be contacted for research
- Participant must be willing and capable to provide consent.
- Participants shall be generally healthy as deemed acceptable by the principal investigator
- Men and women will be participant in this study. Women cannot be pregnant during this study.
Exclusion Criteria
- Surgical History - Gastric surgery, pacemaker placement, weight loss surgery, metabolic and obstetric surgery.
- Smokers will be excluded from the study.
- Medications: Insulins, common diabetic drugs, anti-hyperglycemic drugs, beta blockers cardiac selective, beta-blockers noncardiac selective, oral steroids, opioids anti-depressants, and hormones
- Conidiations and Diagnosis: Disorder of coronary artery, hepatic failure, gastroparesis, disorder of the adrenal gland, drug related disorders, substance abuse, malignant neoplastic disease, psychotic disorders, disorder of skeletal muscle, finding of brain, chronic kidney disease, renal failure syndrome, disorder of pulmonary circulation, cerebrovascular disease, neuro developmental disorder, disorder of immune function, disorder of central nervous system.
- Participants are not to have an abnormal value as part of a lipid panel within the past 6 months.
- Participant will be excluded if they have recreational drug use or a history of alcohol abuse
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
- Current or past participation within a specified timeframe in another clinical trial, as warranted by the administration of this intervention.
- Participant will be excluded if they have epilepsy.
- Participant will be excluded if they have cranial metal/device implants
- Participant will be excluded if they are pregnant
Recruiting US locations
Mayo Clinic
Rochester, MN 55905
Site contact: Emmett Oldham · 507-538-7772 · oldham.emmett@mayo.edu
Study contacts (from the official record)
- Emmett Oldham · 507-538-7772 · oldham.emmett@mayo.edu
Similar studies in Minnesota
All diabetes studies in Minnesota →- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Alcamena Stem Cell Therapeutics
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Mankato, MN + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Minneapolis, MN + 121 other US sites
- Eligibility basics
- Ages 55+